SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-048919
Filing Date
2022-04-22
Accepted
2022-04-22 16:01:47
Documents
6
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223566-1_def14a.htm DEF 14A 1348273
2 GRAPHIC lg_caratmtherap-4c.jpg GRAPHIC 39308
3 GRAPHIC sg_christopherposner-bwlr.jpg GRAPHIC 144810
4 GRAPHIC sg_scottterrillion-fpo.jpg GRAPHIC 23524
5 GRAPHIC tm223566d1-px_01pagebw.jpg GRAPHIC 491400
6 GRAPHIC tm223566d1-px_02pagebw.jpg GRAPHIC 368273
  Complete submission text file 0001104659-22-048919.txt   2818447
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36279 | Film No.: 22845432
SIC: 2834 Pharmaceutical Preparations